CLINICAL EFFICIENCY OF ZINC PYRITHIONE TO TREAT ATOPIC DERMATITIS IN CHILDREN
Abstract
Atopic dermatitis is one of the most widespread children’s diseases, it has a chronic recurrent clinical course, may be often complicated with the secondary infection. This necessitates the choice of a medication to impact all stages of the disease process with a high safety profile. This digest is devoted to activated zinc pyrithione. Overall, currently available data make it possible to state that this agent is one of the most effective and safest products to be used for a local therapy of atopic dermatitis in children.
Key words: atopic dermatitis, activated zinc pyrithione, children
Key words: atopic dermatitis, activated zinc pyrithione, children
About the Authors
D.S. Korostovtsev
Saint-Petersburg Pediatric Medical Academy
Russian Federation
Russian Federation
A.N. Pampura
Moscow Research Institute of Pediatrics and Children’s Surgery, Russian Medical Technologies
Russian Federation
Russian Federation
R.S. Fassakhov
Kazan Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
E.O. Sukmanskaya
Kazan Research Institute of Epidemiology and Microbiology
Russian Federation
Russian Federation
F.I. Petrovsky
Khanty-Mansiysk State Medical Institute
Russian Federation
Russian Federation
Review
For citations:
Korostovtsev D., Pampura A., Fassakhov R., Sukmanskaya E., Petrovsky F. CLINICAL EFFICIENCY OF ZINC PYRITHIONE TO TREAT ATOPIC DERMATITIS IN CHILDREN. Pediatric pharmacology. 2009;6(1):64-69.
Views:
630
Email this article 